Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2939014rdf:typepubmed:Citationlld:pubmed
pubmed-article:2939014lifeskim:mentionsumls-concept:C1705487lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C1319927lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C1705486lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C0597719lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C0033371lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C0037663lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C0015011lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C0056855lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C1705489lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:2939014lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:2939014pubmed:issue3lld:pubmed
pubmed-article:2939014pubmed:dateCreated1986-6-2lld:pubmed
pubmed-article:2939014pubmed:abstractTextThis study investigated the effects of long-term cyproterone-acetate (CA) treatment on the hypothalamus-pituitary-adrenal axis and further on the release of prolactin and growth hormone. Thirty-one male-to-female transsexuals, treated at least 3 months either with 100 mg CA alone or in combination with 50 micrograms ethinyloestradiol (EO)/day, were studied. In all of them the cortisol response to 250 micrograms Synacthen administration was comparable to that measured in controls. Six subjects treated with CA alone (group I) and six subjects treated with CA + EO (group II) underwent an insulin-hypoglycemia test. Seven eugonadal men served as controls. Compared with control values: in two subjects of group I and one subject of group II a low cortisol response was found. The mean growth hormone response was found to be lower in both groups, whereas the mean prolactin response was lower in group I.lld:pubmed
pubmed-article:2939014pubmed:languageenglld:pubmed
pubmed-article:2939014pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939014pubmed:citationSubsetIMlld:pubmed
pubmed-article:2939014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2939014pubmed:statusMEDLINElld:pubmed
pubmed-article:2939014pubmed:monthMarlld:pubmed
pubmed-article:2939014pubmed:issn0018-5043lld:pubmed
pubmed-article:2939014pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:2939014pubmed:authorpubmed-author:GoorenL JLJlld:pubmed
pubmed-article:2939014pubmed:authorpubmed-author:de VriesC PCPlld:pubmed
pubmed-article:2939014pubmed:issnTypePrintlld:pubmed
pubmed-article:2939014pubmed:volume18lld:pubmed
pubmed-article:2939014pubmed:ownerNLMlld:pubmed
pubmed-article:2939014pubmed:authorsCompleteYlld:pubmed
pubmed-article:2939014pubmed:pagination203-5lld:pubmed
pubmed-article:2939014pubmed:dateRevised2009-2-19lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:meshHeadingpubmed-meshheading:2939014-...lld:pubmed
pubmed-article:2939014pubmed:year1986lld:pubmed
pubmed-article:2939014pubmed:articleTitleThe effect of cyproterone acetate alone and in combination with ethinylestradiol on the hypothalamic pituitary adrenal axis, prolactin and growth hormone release in male-to-female transsexuals.lld:pubmed
pubmed-article:2939014pubmed:publicationTypeJournal Articlelld:pubmed